A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 1,799,232 shares of AVTE stock, worth $4.68 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,799,232
Previous 1,799,232 -0.0%
Holding current value
$4.68 Million
Previous $2.99 Million 25.92%
% of portfolio
0.46%
Previous 0.4%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$1.41 - $30.75 $338,423 - $7.38 Million
-240,017 Reduced 11.77%
1,799,232 $2.99 Million
Q1 2023

May 15, 2023

BUY
$19.17 - $27.7 $416,525 - $601,865
21,728 Added 1.08%
2,039,249 $41.1 Million
Q4 2022

Feb 14, 2023

SELL
$15.92 - $30.52 $4.94 Million - $9.47 Million
-310,388 Reduced 13.33%
2,017,521 $59.1 Million
Q3 2022

Nov 09, 2022

SELL
$14.77 - $25.79 $4.58 Million - $8 Million
-310,388 Reduced 11.76%
2,327,909 $38.6 Million
Q2 2022

Aug 03, 2022

SELL
$10.8 - $16.91 $5.03 Million - $7.87 Million
-465,582 Reduced 15.0%
2,638,297 $41.2 Million
Q4 2021

May 16, 2022

BUY
$9.14 - $21.54 $28.4 Million - $66.9 Million
3,103,879 New
3,103,879 $36.6 Million

Others Institutions Holding AVTE

About Aerovate Therapeutics, Inc.


  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $63.6M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.